Danaher Corporation DHR has been benefiting from strength in its Biotechnology segment. In the third quarter of 2025, the segment’s core revenues increased 6.5% on a year-over-year basis, supported

Golar LNG Limited (GLNG) is currently mired in multiple headwinds, which, we believe, have made it an unimpressive investment option.

Let’s delve deeper.

Key Risks to Watch

Southward Earnings

Novo Nordisk NVO is a leading player in the obesity market, driven by its blockbuster GLP-1 therapy Wegovy (semaglutide). However, despite being a core growth driver, Wegovy’s sales momentum has

Cloud computing is increasingly gaining market traction as it reduces the operating costs of maintaining on-site data centers and deploying IT experts to manage the infrastructure, making it a

The broader U.S. equity markets witnessed a downtrend over the past few days, exhibiting a four-day losing streak on concerns regarding the economic health and the increasing valuation of AI firms

For Immediate Release

Chicago, IL – December 18, 2025 – Zacks Equity Research shares Ciena Corporation CIEN, as the Bull of the Day and Jack in the Box JACK, as the Bear of the Day. In addition

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service